PPARγ maintains the metabolic heterogeneity and homeostasis of renal tubules

Abstract

BackgroundThe renal tubules, which have distant metabolic features and functions in different segments, reabsorb >99% of approximately 180 l of water and 25,000 mmol of Na + daily. Defective metabolism in renal tubules is involved in the pathobiology of kidney diseases. However, the mechanisms underlying the metabolic regulation in renal tubules remain to be defined.MethodsWe quantitatively compared the proteomes of the isolated proximal tubules (PT) and distal tubules (DT) from C57BL/6 mouse using tandem mass tag (TMT) labeling-based quantitative mass spectrometry. Bioinformatics analysis of the differentially expressed proteins revealed the significant differences between PT and DT in metabolism pathway. We also performed in vitro and in vivo assays to investigate the molecular mechanism underlying the distant metabolic features in PT and DT.FindingsWe demonstrate that the renal proximal tubule (PT) has high expression of lipid metabolism enzymes, which is transcriptionally upregulated by abundantly expressed PPARα/γ. In contrast, the renal distal tubule (DT) has elevated glycolytic enzyme expression, which is mediated by highly expressed c-Myc. Importantly, PPARγ transcriptionally enhances the protease iRhom2 expression in PT, which suppresses EGF expression and secretion and subsequent EGFR-dependent glycolytic gene expression and glycolysis. PPARγ inhibition reduces iRhom2 expression and increases EGF and GLUT1 expression in PT in mice, resulting in renal tubule hypertrophy, tubulointerstitial fibrosis and damaged kidney functions, which are rescued by 2-deoxy-d-glucose treatment.InterpretationThese findings delineate instrumental mechanisms underlying the active lipid metabolism and suppressed glycolysis in PT and active glycolysis in DT and reveal critical roles for PPARs and c-Myc in maintaining renal metabolic homeostasis. FUND: This work was supported by the National Natural Science Foundation of China (grants 81572076 and 81873932; to Q.Z.), the Applied Development Program of the Science and Technology Committee of Chongqing (cstc2014yykfB10003; Q.Z.), the Program of Populace Creativities Workshops of the Science and Technology Committee of Chongqing (Q.Z.), the special demonstration programs for innovation and application of techniques (cstc2018jscx-mszdX0022) from the Science and Technology Committee of Chongqing (Q.Z.).

Aldosterone Induces DNA Damage and Activation of Nrf2 Mainly in Tubuli of Mouse Kidneys

“…Within the cortex we found the highest amount of pNrf2 in cells positive for the distal tubular cell/early collecting duct cell marker calbindin. This is in accordance with other publications localizing Nrf2, its mRNA or one of its targets, heme oxygenase 1 in the kidney [ 34 , 35 , 36 ]. When quantifying total Nrf2, a tendential increase was found.…”

PPARγ and Its Agonists in Chronic Kidney Disease

“…All PPARs have been detected in rodent and human kidney, including glomeruli, medullary collecting duct, and pelvic urothelium. Renal proximal tubule expresses lipid metabolism-related enzymes that can upregulate transcriptional activity by sufficient expression of PPARc [68]. Kidney can process free fatty acids (FFAs), including reabsorption by proximal tubule and metabolism within mitochondria of proximal tubule [69].…”

Pharmacologic inhibition of RGD‐binding integrins ameliorates fibrosis and improves function following kidney injury

“…However, importantly, reduced expression was abrogated by CWHM‐12 treatment. In addition to being a biomarker for CKD, several studies support a functional role for EGF signaling in kidney fibrosis (Kok, Falke, Goldschmeding, & Nguyen, ; Liu et al, ; Lyu et al, ). A recent study identified a metabolic switch from oxidative phosphorylation to glycolysis associated with tubulointerstitial fibrosis and progressive CKD in human kidneys (Lemos et al, ).…”